BEACON of hope in BRAFV600E CRC

被引：0
|
作者：
David Killock
机构：
[1] Nature Reviews Clinical Oncology,
来源：
Nature Reviews Clinical Oncology | 2019年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：723 / 723
相关论文
共 50 条
  • [41] Confocal microscopy characterization of BRAFV600E mutated melanomas
    Ruini, Cristel
    Manfredini, Marco
    Pellacani, Giovanni
    Mandel, Victor D.
    Tomasi, Aldo
    Ponti, Giovanni
    MELANOMA RESEARCH, 2015, 25 (04) : 367 - 371
  • [42] TARGETED THERAPY FOR BRAFV600E MUTANT MALIGNANT ASTROCYTOMA
    Nicolaides, Theodore
    Hariono, Sujatmi
    Barkovich, Krister
    Hashizume, Rintaro
    Rowitch, David
    Weiss, William
    Sheer, Denise
    Baker, Suzanne
    Paugh, Barbara
    Waldman, Todd
    Li, Huifang
    Jones, Chris
    Forshew, Tim
    James, David
    NEURO-ONCOLOGY, 2011, 13 : 112 - 112
  • [43] Frequency of BRAFV600E mutation in atypical genital nevi
    Nguyen, L. P.
    Emley, A.
    Wajapeyee, N.
    Mahalingam, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S24 - S24
  • [44] Mechanisms of TERT Reactivation and Its Interaction with BRAFV600E
    Song, Young Shin
    Park, Young Joo
    ENDOCRINOLOGY AND METABOLISM, 2020, 35 (03) : 515 - 525
  • [45] ABSENCE OF BRAFV600E MUTATIONS IN PRIMARY MENINGIOMA TUMOURS
    Flannery, T.
    Sughrue, M.
    Hashizume, R.
    James, C.
    McDermott, M.
    NEURO-ONCOLOGY, 2010, 12 : 8 - 8
  • [46] Expression of AID in malignant melanoma with BRAFV600E mutation
    Okura, Risa
    Yoshioka, Haruna
    Yoshioka, Manabu
    Hiromasa, Kana
    Nishio, Daisuke
    Nakamura, Motonobu
    EXPERIMENTAL DERMATOLOGY, 2014, 23 (05) : 347 - 348
  • [47] Encorafenib plus cetuximab with or without binimetinib for BRAFV600E metastatic colorectal cancer (mCRC): Relationship between carcinoembryonic antigen (CEA) and clinical outcomes from BEACON CRC
    Grothey, A.
    Kopetz, S.
    Yaeger, R.
    Van Cutsem, E.
    Wasan, H.
    Desai, J.
    Ciardiello, F.
    Yoshino, T.
    Maharry, K.
    Christy-Bittel, J.
    Gollerkeri, A.
    Tabernero, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S243 - S243
  • [48] BRAFV600E mutation analysis in circulating tumor cells
    Pace, Margaret
    Melnikova, Vladislava O.
    Brandl, Kerry
    Kahn, Larry
    Woo, Jacky
    Davis, Darren W.
    CANCER RESEARCH, 2011, 71
  • [49] Light-controlled inhibition of BRAFV600E kinase
    Hoorens, Mark W. H.
    Ourailidou, Maria E.
    Rodat, Theo
    van der Wouden, Petra E.
    Kobauri, Piermichele
    Kriegs, Malte
    Peifer, Christian
    Feringa, Ben L.
    Dekker, Frank J.
    Szymanski, Wiktor
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 179 : 133 - 146
  • [50] Targeting BRAFV600E in thyroid carcinoma:: therapeutic implications
    Mitsiades, Constantine S.
    Negri, Joseph
    McMullan, Ciaran
    McMillin, Douglas W.
    Sozopoulos, Elias
    Fanourakis, Galinos
    Voutsinas, Gerassimos
    Tseleni-Balafouta, Sophia
    Poulaki, Vassiliki
    Batt, David
    Mitsiades, Nicholas
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (03) : 1070 - 1078
12345